
Oncotelic Therapeutics
Oncotelic develops PDAOAI, a knowledge-discovery platform for drug discovery and AI-powered GMP manufacturing.
- 22
- Public company
- Aguora Hills, CA, USUnited States
Oncotelic Therapeutics descends from OXiGENE, which was later renamed Mateon Therapeutics before becoming Oncotelic. PDAOAI is Oncotelic’s knowledge-discovery platform for drug discovery and AI-powered GMP manufacturing.
Oncotelic Therapeutics focuses OT-101, an antisense against TGF-β2, on solid tumors, with a focus on adult brain cancer and pediatric DIPG.
Similar Companies

GT Biopharma
gtbiopharma.com

Oncternal Therapeutics
oncternal.com

General Oncology

Champions Oncology
Oncologix Tech

Oncospace
oncospace.com

Oncomatryx
oncomatryx.com
Otricath
otricath.com

Ostentus Therapeutics

Ensem Therapeutics
ensemtx.com

Presage Biosciences
presagebio.com

Biogenesis Trials
mybiogenesis.com

Incyte
incyte.com

Traws Pharma
trawspharma.com

Predictive Oncology

Aktis Oncology
aktisoncology.com

Onc.AI
onc.ai

OncoTartis

OnCusp Therapeutics
oncusptx.com

Revolution Medicines
revmed.com
Quick Facts
Who are Oncotelic Therapeutics' competitors?
Companies similar to Oncotelic Therapeutics include GT Biopharma, Oncternal Therapeutics, General Oncology and Champions Oncology.
When was Oncotelic Therapeutics founded?
Oncotelic Therapeutics was founded in 1996.
Where is Oncotelic Therapeutics' headquarters located?
Oncotelic Therapeutics' headquarters is located in Aguora Hills, CA, US.
When was Oncotelic Therapeutics' last funding round?
Oncotelic Therapeutics' most recent funding round was for $711.8k (USD) in July 2026.
How much disclosed funding has Oncotelic Therapeutics raised?
As of Jul 10, 2026, Oncotelic Therapeutics has disclosed funding of $711.8k (USD). Undisclosed round amounts are excluded.
How many employees does Oncotelic Therapeutics have?
Oncotelic Therapeutics has 22 employees as of Feb 6, 2024.
Classification
- Model
- Customer
- Main Product
- Tags
- Also Known As
- Oncotelic Therapeutics, Inc.
- Mateon Therapeutics
- Mateon Therapeutics, Inc.
- OXiGENE, Inc.
- Headquarters
- 29397 Agoura Rd., #107
- Aguora Hills, CA, 91301
- US
- Ticker
- OTLC
- SEC CIK
- 0000908259
- EIN
- 13-3679168
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 2800Chemicals And Allied Products
- 2830Drugs
- 2834Pharmaceutical Preparations
- ISIC
- 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
- Industry
- —Biotechnology Companies
- —Health Care Companies
- —Medical Organizations
- —Pharmaceutical Companies
Show 16 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 325414Biological Product (except Diagnostic) Manufacturing
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 623000Nursing and Residential Care Facilities
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 2836Biological Products, Except Diagnostic Substances
- 4000Railroad Transportation
- 8000Health Services
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8040Offices And Clinics Of Other Health Practitioners
- 8730Research, Development, And Testing Services
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
- 8731Commercial Physical and Biological Research